ArticleBMJ open2025
What is the current status of transplant pharmacy services in China? A nationwide cross-sectional survey.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Improving medication safety and efficiency in hospital pharmacy through a pharmacist-led, low-code mobile application: a prospective study.Frontiers in public health · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPharmacists are vital to the multidisciplinary care for transplant patients, but the workforce of their work in China remains unclear.
objectiveTo assess the current status of transplant pharmacists' work in China through a national workforce survey to evaluate service provision across transplantation stages and pharmacist capacity. DESIGN, SETTING AND
participantsNationwide cross-sectional questionnaire-based study (25 March-1 April 2024) involving 91 transplant centres performing>90% of China's organ transplants. MAIN OUTCOMES AND MEASURES: Pharmacy items and duration provided to patients by pharmacists at each transplant centre and used to calculate full-time equivalents (FTEs).
resultsService provision varied substantially across centres, with only 0.8 pharmacists per 100 transplant patients nationally. Current workforce require 2.6 FTEs/100 transplants for comprehensive services, reducible to 1.2 FTEs if non-clinical duties are excluded. Key challenges included service inconsistency, limited patient coverage and inadequate standardisation/digitalisation. Primary barriers were excessive non-service workloads and insufficient performance incentives. Addressing these issues is an effective way to change the current status of pharmacy services for transplant recipients in China.
conclusionsA national workforce survey revealed significant gaps in transplant pharmacy services in China, particularly in standardisation and digitalisation. To address these issues, key steps include reducing non-essential workloads for transplant clinical pharmacists, enhancing performance incentives, expanding the number of transplant pharmacists and developing standardised service protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.